| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Tottori University Hospital |
| Information provided by: | Tottori University Hospital |
| ClinicalTrials.gov Identifier: | NCT00664222 |
Purpose
The purpose of this study is to evaluate the effects of spironolactone and furosemide on insulin resistance in patients with chronic heart failure.
| Condition | Intervention | Phase |
|
Chronic Stable Heart Failure |
Drug: spironolactone + furosemide |
Phase IV |
| MedlinePlus related topics: | Heart Failure |
| Drug Information available for: | Insulin Spironolactone Furosemide |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Active Control, Crossover Assignment, Efficacy Study |
| Official Title: | Effects of Spironolactone on Insulin Resistance in Patients With Chronic Heart Failure |
| Enrollment: | 16 |
| Study Start Date: | January 2004 |
| Estimated Study Completion Date: | December 2005 |
Diuretics is useful in CHF patients. On the other hand, they deteriorate glucose metabolism. Therefore, the purpose of this study is to evaluate the effects of spironolactone and furosemide on insulin resistance in patients with chronic heart failure.
Eligibility
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations More Information
| Responsible Party: | Center for Clinical Residency Program, Tottori University Hospital ( Kazuhide Ogino, MD ) |
| Study ID Numbers: | #344.1 |
| First Received: | April 18, 2008 |
| Last Updated: | April 21, 2008 |
| ClinicalTrials.gov Identifier: | NCT00664222 |
| Health Authority: | Japan: Ministry of Health, Labor and Welfare |
|
|
|
|
|
|
